US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
RSS Feeds

Biotechnology Industry Research & Market Reports

12  13  14  15    17    19  20  21  
Anti-CD33 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD33 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD33 Antibody- ...  |  read more...
USD 1,250
Anti-CD38 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD38 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD38 Antibody- ...  |  read more...
USD 1,250
Anti-CD52 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD52 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD52 Antibody- ...  |  read more...
USD 1,250
Anti-CD80 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD80 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD80 Antibody- ...  |  read more...
USD 1,250
Anti-CD95 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD95 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD95 Antibody- ...  |  read more...
USD 1,250
Fibroblast Growth Factor Receptor (FGFR) Agonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... (FGFR) Agonists. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Fibroblast Growth Factor Receptor (FGFR) Agonists Report helps to identify emerging players ...  |  read more...
USD 1,250
Fibroblast Growth Factor Receptor (FGFR) Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... (FGFR) Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Fibroblast Growth Factor Receptor (FGFR) Inhibitors Report helps to identify emerging players ...  |  read more...
USD 1,250
Fibroblast Growth Factor Receptor 1 (FGFR1) Agonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... Factor Receptor 1 (FGFR1) Agonists. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Fibroblast Growth Factor Receptor 1 (FGFR1) Agonists Report helps ...  |  read more...
USD 1,250
Fibroblast Growth Factor Receptor 1 (FGFR1) Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... Factor Receptor 1 (FGFR1) Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Fibroblast Growth Factor Receptor 1 (FGFR1) Inhibitors Report helps ...  |  read more...
USD 1,250
Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... Factor Receptor 4 (FGFR4) Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors Report helps ...  |  read more...
USD 1,250
Interferon Gamma Receptor (IFNGR) Binders -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Interferon Gamma Receptor (IFNGR) Binders Report helps to identify emerging players with potentially strong product ...  |  read more...
USD 1,250
Silent Information Regulator 2 Protein (Sir2 Protein or Sirtuin) Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... pipeline assets across the Silent Information Regulator 2 Protein (Sir2 Protein or Sirtuin) Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The ...  |  read more...
USD 1,250
Library Preparation and Target Enrichment for Next Generation Sequencing Product Markets
3/26/2015 | published by: Kalorama Information
... they have been increasingly moving into more labs and new types of research projects in a virtuous cycle. The capabilities of next-generation sequencer (NGS) systems, along with the growing availability of vast amounts of annotated ...  |  read more...
USD 3,995
Mergers and Acquisitions in the IVD Market
2/17/2015 | published by: Kalorama Information
... for a host of new protein and molecular markers. No company, big or small, owns all of the technology needed to develop these new tests and systems. They have to get the pieces they do ...  |  read more...
USD 500
Lab Automation Markets, 4th Edition (Systems [Sample Transport, Specimen Handling, Plate Readers, Storage & Retrieval, Robotics, LIMS], Key Companies, Forecasts and Trends)
3/17/2015 | published by: Kalorama Information
... laboratories where systems are improving work flow and adding speed and efficiency. Over the years, many laboratories in North America, Europe and elsewhere have installed fully functional automation systems, as well as individual automated systems. ...  |  read more...
USD 4,200
Next Generation Sequencing (NGS) Markets 2015 (Systems, Consumables, Services, Acquisitions, Agreements, Competitive Analysis, Platforms, Applications, Brand Ownership and Other Trends)
1/23/2015 | published by: Kalorama Information
... sequencing has attracted many companies, researchers, and investors. DNA sequencing has already become a large market, and clinical applications of DNA sequencing are being developed and commercialized.  More than ever, marketers of advanced equipment and ...  |  read more...
USD 4,200
Stem Cell Therapeutics Markets (Cardiovascular and Circulatory Diseases, Endocrine Diseases, Digestive Disorders, Musculoskeletal, Nervous System, Cancer, Others)
10/9/2014 | published by: Kalorama Information
... new regenerative therapies. Stem cells have become effective tools in blood diseases, musculoskeletal diseases, digestive disorders and many other areas. Kalorama Information’s Stem Cell Therapeutics Markets conducts in-depth research into the stem cell market opportunity ...  |  read more...
USD 3,995
Proteomics Markets for Clinical IVD Applications and Research Applications (Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Other Technologies)
9/4/2014 | published by: Kalorama Information
... proteins. This includes the study of which proteins are expressed, when and where they are expressed, structure of proteins, roles of proteins, and interactions of proteins. Proteomics is a large field that has focused on ...  |  read more...
USD 4,200
Companion Diagnostics Markets (Cancer, Cardiovascular and Blood, Metabolic, Infection, Neurological, Others)
8/8/2014 | published by: Kalorama Information
... with several of them part of a routine diagnostic and treatment plan. This report tracks these developments and provides detailed examples of drug-test pairs.  It also provides market estimation and forecast models for business planning. ...  |  read more...
USD 3,995
qPCR and dPCR Markets (Instruments, Reagents, Software/Services, Clinical and Research Markets)
10/22/2014 | published by: Kalorama Information
... is mainly a workhorse in the research laboratory, while dPCR is helping to push the potential for diagnostic applications due to its sensitivity, precision, robustness and reproducibility. qPCR has been established for a broad range ...  |  read more...
USD 4,200
Biopharmaceutical and Vaccine Production Markets (Mammalian Cell Production, Microbial Cell Production Market, Monoclonal Antibody Manufacturing, Other Recombinant Protein Manufacturing, Vaccine Manufacturing, Insulin Manufacturing Market)
8/29/2014 | published by: Kalorama Information
... stages of clinical drug testing for new biopharmaceuticals, as manufacturers decide when and how to risk production capital to upscale while anticipating FDA or EMA approval. During the past five years, estimates for biopharmaceuticals have ...  |  read more...
USD 3,995
The Market for Personalized Gene Therapy Treatments for Cancer
12/23/2014 | published by: Kalorama Information
... research. It involves modification of genes instead of using a surgical method or chemical drug product. Essentially, gene therapies replace an abnormal gene with a normal gene, or changes the response of a gene (turn ...  |  read more...
USD 3,995
miRNA Research and Diagnostics Markets
9/4/2014 | published by: Kalorama Information
... the post-transcriptional level. These small bits of RNA, members of a class of non-translated molecules that do not produce protein, shut off gene transcription by base pairing with the target molecules.  They are now recognized as ...  |  read more...
USD 2,995
The 2016-2021 World Outlook for Microplate Instrumentation and Supplies
4/6/2015 | published by: Icon Group International, Inc.
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow ...  |  read more...
USD 995
Digital PCR (dPCR) and qPCR Market by Technology, Product (Instruments, Reagents, Software), End User (Research Lab, Academia, Hospitals, Pharmaceutical & Biotechnology Cos, CROs), Application (Research, Diagnostic, Forensic) Global Forecast to 2019
2/13/2015 | published by: MarketsandMarkets
... PCR (dPCR) and qPCR market is estimated to grow at a CAGR of 7.8% from 2014 to 2019. Although the mature markets (such as the U.S., Germany, France, and U.K.) hold larger shares in the ...  |  read more...
USD 4,650
12  13  14  15    17    19  20  21